THE GOLD STANDARD IN THIRD-PARTY CERTIFICATION AND TESTING : +1-800-920-6605, info@bscg.org
Oct 07, 2026
A supplement brand should request residual solvent testing whenever a botanical extract was produced with an organic solvent, whenever the extraction solvent is unknown, and whenever a supplier, process, or solvent changes. Water-only extracts and dried herb powders that never contacted an organic solvent have no solvent residue to test for. Finished products need their own residual solvent testing in four cases. These are several solvent-based extracts in one formula, a large daily dose, concentrated oils or resins, and hemp or CBD rules that require final product testing.
The decision rests on two sources of authority. 21 CFR 111.70(b) requires manufacturers to set limits on contaminants for every component, and 21 CFR 111.75 requires them to verify those limits by testing or by a qualified supplier certificate of analysis. The limits themselves usually come from USP General Chapter <467> and ICH Q3C.
Residual solvent testing is a laboratory analysis that measures organic volatile chemicals, such as hexane, methanol, or ethanol, left behind in an ingredient or finished product after extraction or processing. Laboratories typically perform it by headspace gas chromatography and compare results against limits set by USP General Chapter <467> and ICH Q3C, which group solvents into three toxicity classes.
Ask the supplier for the extraction solvent, the solvent-to-herb ratio, and any post-processing solvents before selecting a test. The analytical panel should target the solvents actually used, plus the USP Class 1 solvents that no extract should contain. A generic panel that omits the supplier's actual solvent does not verify the specification.
One detail often goes unreported. Supercritical CO2 is not a volatile organic solvent on the USP or ICH lists, so CO2 extraction itself leaves no organic solvent residue. Post-extraction refining steps may still use ethanol or other solvents, and brands should ask whether any were used. BSCG's guidance on botanical testing for supplement brands recommends asking which solvents were used and targeting those solvents in the request.
USP <467> and ICH Q3C sort solvents into three classes. The class determines how strict the limit is and how much effort the specification deserves.
Class 1 solvents are known or suspected human carcinogens or environmental hazards. ICH Q3C sets concentration limits of 2 ppm for benzene, 4 ppm for carbon tetrachloride, 5 ppm for 1,2-dichloroethane, 8 ppm for 1,1-dichloroethene, and 1,500 ppm for 1,1,1-trichloroethane. AHPA states these solvents are not appropriate for use in herbal extract manufacture. ICH Q3C indicates Class 1 solvents should be avoided, so a Class 1 screen functions as a baseline check that the extract was not exposed to them.
Class 2 solvents carry toxicity that justifies a permitted daily exposure (PDE). ICH Q3C expresses each PDE in milligrams per day and converts it to a concentration limit assuming a 10 gram daily dose. Examples relevant to botanicals include hexane at 290 ppm (PDE 2.9 mg/day), methanol at 3,000 ppm (PDE 30 mg/day), toluene at 890 ppm, dichloromethane at 600 ppm, and acetonitrile at 410 ppm.
Class 3 solvents include ethanol, acetone, ethyl acetate, isopropanol, and heptane. ICH Q3C considers amounts up to 50 mg per day acceptable without further justification, which equals 5,000 ppm at a 10 gram daily dose. AHPA notes one exception: the 50 mg per day ethanol limit does not apply to liquid extracts formulated to contain ethanol as an ingredient.
USP <467> offers two ways to apply these limits. Option 1 uses the fixed ppm values above, which assume a 10 gram daily dose. Option 2 calculates the actual daily exposure from the measured concentration and the real daily serving, then compares the total against the PDE. For products with a daily dose at or below 10 grams, Option 1 applies directly. Option 2 requires a documented calculation and must be used when the daily dose exceeds 10 grams or when any component exceeds its Option 1 limit.
Part 111 allows a brand to rely on a supplier certificate of analysis (COA) for component specifications other than identity, but only under conditions. 21 CFR 111.75(a)(2)(ii) sets four conditions. The brand must qualify the supplier by confirming the supplier's results. The COA must state the method, the limits, and the actual results. The qualification must be documented and periodically re-confirmed. A COA that says only "complies with USP <467>" with no method or numbers does not meet that standard.
In practice this creates a testing schedule. Independent residual solvent testing applies at supplier qualification, at periodic re-confirmation, and after any process change. Between those points, a complete COA from a qualified supplier can cover routine lots. BSCG's guide to reading a supplement COA explains how to check whether residual solvent results are reported with methods and limits, and why a raw material COA does not describe the finished product.
Finished product testing for residual solvents is not automatic. 21 CFR 111.75(c) requires manufacturers to verify finished batches against specifications, including contamination limits, but it lets quality control select which specifications to verify at the finished batch stage. Under 111.75(d), a specification can be exempted from finished batch verification when component testing and process controls ensure it is met, provided the reasoning is documented and approved.
Several conditions weaken that reasoning and point toward finished product testing:
When none of these conditions apply, and component results are current and documented, a brand can reasonably verify residual solvents at the ingredient level and document the 111.75(d) rationale for the finished product.
Hemp and CBD extracts combine several risk factors: lipid-rich matrices, hydrocarbon or ethanol extraction, and further refining steps. A 2024 study in Frontiers in Pharmacology tested 202 commercially available CBD products and detected residual solvents 446 times across 181 of them. The highest concentrations were reported for hexane, m/p-xylene, methanol, and o-xylene. The authors report that about 1 percent of residual solvent results exceeded more than one regulatory threshold, which shows that detection and violation are different findings. The frequency of detection still confirms that solvents routinely carry through to finished CBD products.
State rules add a second layer. State cannabis and hemp programs commonly publish their own solvent lists and numeric limits, and some state hemp plans filed with USDA set limits that differ from USP values. For example, the Alaska industrial hemp plan lists product-level limits for specific solvents. Brands selling hemp products across states should treat the most restrictive applicable rule as the specification and test finished lots where a state requires it.
BSCG's Certified CBD program reviews hemp supplier qualification, raw material specifications and testing, and finished product specifications as part of its initial assessment. Its published recurring panel covers cannabinoid profile, THC limits, and a drug screen on every lot, with heavy metals, pesticides, and microbiological agents every tenth lot. Residual solvent testing for hemp extracts is available as an additional service and should be scoped to the product's extraction history and state requirements.
Testing adds little value for materials that never contacted an organic solvent. Whole dried herbs, cut and sifted botanicals, simple herb powders, and extracts made only with water or steam fall into this group. For these materials, identity, pesticide residues, heavy metals, and microbial limits are the relevant contaminant controls, as described in BSCG's botanical testing guidance.
Two cautions apply. A "water extract" description should be confirmed with the supplier so that any co-solvent is identified. And a facility that handles solvents for other products can still introduce cleaning residues, which is a facility control issue rather than an ingredient issue.
The request should name the solvents, the method, and the limits. USP <467> describes headspace gas chromatography with flame ionization detection as its primary procedure, and laboratories also use GC-MS for added selectivity and lower detection limits. FDA guidance on residual solvents in drug products accepts alternative validated procedures, and the same principle applies when a supplement laboratory adapts the method.
Four specifications belong in every request:
BSCG offers residual solvent testing on an a la carte basis for USP Class 1, 2, and 3 solvents. The primary panel covers the five Class 1 solvents, and additional classes are added based on the extraction history. Testing runs through ISO/IEC 17025 accredited laboratory partners. The standard contaminant panel in BSCG's Certified Quality program covers heavy metals, pesticides, and microbiological agents, so brands with solvent-based extracts add residual solvents to the scope rather than assuming it is included.
Residual solvent control works best as part of supplier qualification rather than as an isolated test. A complete specification for a solvent-based extract includes identity, marker compound strength, heavy metals, pesticides, microbial limits, and residual solvents, with each limit tied to a recognized standard. BSCG's ingredient certification review examines supplier qualification, specifications, and contaminant testing against 21 CFR 111.
Retailer requirements can also shape the scope. Online marketplaces publish testing requirements for dietary supplements that currently emphasize label claims, heavy metals, microbiological agents, and pesticides for botanical products, as summarized on BSCG's Amazon testing page. Secondary reports indicate that some marketplace programs have included residual solvent testing for certain products. Brands should confirm the current analyte list for each channel directly with the retailer, because these requirements change.
Not by name. 21 CFR 111.70(b)(3) requires limits on contaminants that could adulterate the product, and 21 CFR 111.75 requires verification of those limits. For a solvent-based extract, residual solvents are a foreseeable contaminant, so the regulation effectively requires a specification and a verification approach. USP <467> and ICH Q3C supply the limits that industry guidance and manufacturers commonly adopt.
It can be, once the supplier is qualified. A COA can cover routine lots after the brand has confirmed the supplier's results by its own testing and the COA reports methods, limits, and actual results. Step 3 above lists the full conditions in 21 CFR 111.75(a)(2)(ii).
Often yes. Supercritical CO2 leaves no organic solvent residue, but post-extraction refining or dilution steps may use ethanol or other solvents. The test should cover any post-processing solvents the supplier reports, plus the Class 1 solvents as a screen.
Ethanol is a Class 3 solvent, and ICH Q3C considers up to 50 mg per day acceptable, equal to 5,000 ppm at a 10 gram daily dose. AHPA guidance states this limit does not apply to liquid extracts formulated to contain ethanol, where ethanol is an ingredient rather than a residue.
At supplier qualification, at the periodic re-confirmation that 111.75(a)(2)(D) requires, and after any change in solvent, process, or manufacturing site. Finished product panels may add residual solvents for formulas with several solvent-based extracts or high daily servings. The frequency should be documented in the quality system.
Residual solvent testing applies when an organic solvent touched the botanical, when that history is unknown, and when a supplier or process changes. Ingredient-level testing at qualification and re-confirmation covers most risk, while finished product testing becomes necessary for multi-extract formulas, high daily servings, lipid matrices, and hemp products under state rules. USP <467> and ICH Q3C define the limits, 21 CFR 111.70 and 111.75 define the obligation to set and verify them, and AHPA guidance adapts both to herbal extracts.
Two limitations deserve note. Published limits assume a 10 gram daily dose and should be recalculated for products that exceed it. And detection of a solvent does not by itself indicate a violation, as the 2024 CBD survey showed. The comparison against the applicable limit determines compliance.
YouTube Channel
Oliver Catlin Interview
BSCG BLOG
21 CFR 111 or ANSI 455-2: Which Matters More for Sports Nutrition Supplements?
The Catlin Perspective blog widget
THE HISTORY OF BSCG